Packer, M., McMurray, J. J., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M., Andersen, K., Arango, J. L., Arnold, J. M., Bělohlávek, J., Böhm, M., Boytsov, S., Burgess, L. J., Cabrera, W., Calvo, C., Chen, C., Dukat, A., Duarte, Y. C., Erglis, A., Fu, M., Gomez, E., Gonzàlez-Medina, A., Hagège, A. A., Huang, J., Katova, T., Kiatchoosakun, S., Kim, K., Kozan, Ö., Llamas, E. B., Martinez, F., Merkely, B., Mendoza, I., Mosterd, A., Negrusz-Kawecka, M., Peuhkurinen, K., Ramires, F. J., Refsgaard, J., Rosenthal, A., Senni, M., Sibulo, A. S., Silva-Cardoso, J., Squire, I. B., Starling, R. C., Teerlink, J. R., Vanhaecke, J., Vinereanu, D., & Wong, R. C. (2015). angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure. Circulation, 131(1), . http://access.bl.uk/ark:/81055/vdc_100052938437.0x00001f